Arcinova Appoints Christian Dowdeswell as New Managing Director

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

Supreme Group Acquires Pivot Design, Marking a Significant Expansion in Pharma and Rare Disease

MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research collaboration with Syntekabio, Inc., a leading artificial intelligence (AI)-driven drug discovery company, to identify additional disease targets and optimize the therapeutic profile of DA-1241, MetaVia’s novel oral G-Protein-Coupled Receptor 119 (GPR119) agonist.

Antibodies.com expands UK headquarters with new 5x larger facilities in Cambridge to accommodate rapid growth

• Investment in premises on Cambridge Technopark reflects significant milestone in the Company’s growth • Relocation increases logistics and R&D capacity, enabling faster customization and turnaround, strengthening order fulfilment to better support customers in their research and development efforts

Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV

Advarra appoints Brian Hart as Chief Technology Officer

Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research

New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication

New research from the COPD Foundation and Phreesia shows patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life.

InSysBio to launch Immune Response Template Open for QSP modeling

InSysBio announces Immune Response Template (IRT) which was previously available under a license model now is completely free to use. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.

AppOmni Launches New SaaS and AI Security Packages to Tackle Rising Risks

I wanted to share that Software-as-a-Service (SaaS) security leader, AppOmni today announced new innovations to combat rising AI and SaaS risks for healthcare companies: https://appomni.com/press-releases/saas-ai-security-innovation Please let me know if you’d like to speak with them for more about the benefits for healthcare, get a product image, or if I can provide anything further. The rapid adoption of AI has introduced a new and complex attack surface that healthcare cybersecurity teams must manage. AI is an active participant in the SaaS environment; whether embedded in SaaS platforms (such as M365 or Google Workspace) or acting as agents, AI tools constantly access and process sensitive data across the SaaS estate. Healthcare organizations need the ability to identify unsanctioned or shadow AI and SaaS usage, as well as practical strategies to control and monitor AI usage. AppOmni is defining the future of SaaS and AI security by arming organizations of all sizes with the end-to-end controls needed for safe usage of these applications, helping them identify critical risks, protect sensitive data, detect abnormal behavior, and respond to evolving threats. The new features help healthcare understand their risk exposure to AI and implement controls to secure them by identifying both sanctioned and unsanctioned/ shadow AI apps, including AI embedded within SaaS applications. It’s also adding support for 30 new AI and SaaS applications, including ChatGPT Enterprise, Claude, OpenAI, and Anthropic, Cisco Umbrella, Cisco Secure Access, and Gong. And it’s giving healthcare organizations a free 90-day trial of its new AppOmni Foundations package – a SaaS security starter solution for organizations that need to discover shadow SaaS and AI, app users and permission, and detect threats and anomalous activities.

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

Clearwater Launches New Enterprise Cyber Risk Management Solution to Help Healthcare Organizations Reduce Cyber Risk, Strengthen Compliance, and Drive Boardroom Confidence

Clinisys Acquires Orchard Software

Clinisys announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.

Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

Camgenium Develops App to Improve Outcomes for Prostate Cancer Patients Before and After Surgery

Camgenium today announced its partnership with Professor Petre Cristian Ilie, Consultant Urological and Robotic Surgeon at NNUH NHS Foundation Trust, to develop HealthiumPro, a cloud-based innovative software solution. The system has the potential to improve the outcomes of prostate cancer patients by enhancing safety before and after surgery.

Vidir Solutions Introduces VLM Mini for Healthcare, Pharmaceutical, and Laboratory Storage

Compact Vertical Lift Module Engineered for Low-Height Environments with Intelligent Inventory Control

Association for Molecular Pathology Announces 2025 Award Recipients

AMP announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards.

Clearwater Strengthens Cyber Defense in Healthcare and the Defense Industrial Base with Enhanced Threat Intelligence from Google Cloud

Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.